Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 89.39 Million SAR | 156.4% |
| 2022 | -111.7 Million SAR | -354.33% |
| 2021 | 43.92 Million SAR | -71.33% |
| 2020 | 153.17 Million SAR | 258.03% |
| 2019 | -96.92 Million SAR | -115.62% |
| 2018 | 620.4 Million SAR | 220.68% |
| 2017 | 193.46 Million SAR | 20.69% |
| 2016 | 160.3 Million SAR | -38.82% |
| 2015 | 262.03 Million SAR | 8.3% |
| 2014 | 241.94 Million SAR | 16.92% |
| 2013 | 206.92 Million SAR | 3.28% |
| 2012 | 200.35 Million SAR | -6.79% |
| 2011 | 214.94 Million SAR | 12.56% |
| 2010 | 190.96 Million SAR | 12.11% |
| 2009 | 170.33 Million SAR | 258.37% |
| 2008 | -107.55 Million SAR | -10.74% |
| 2007 | -97.12 Million SAR | -194.03% |
| 2006 | 103.29 Million SAR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 87 Million SAR | 240.32% |
| 2024 Q2 | 30.59 Million SAR | -58.68% |
| 2023 Q3 | -16.59 Million SAR | -147.3% |
| 2023 Q1 | 69.41 Million SAR | 201.25% |
| 2023 FY | 63 Million SAR | 156.4% |
| 2023 Q2 | 35.08 Million SAR | -49.45% |
| 2023 Q4 | -62 Million SAR | -273.58% |
| 2022 FY | -111.7 Million SAR | -354.33% |
| 2022 Q4 | -68.55 Million SAR | -82.18% |
| 2022 Q3 | -37.63 Million SAR | 23.76% |
| 2022 Q1 | 37.27 Million SAR | 293.54% |
| 2022 Q2 | -49.36 Million SAR | -232.42% |
| 2021 Q4 | -19.26 Million SAR | -205.56% |
| 2021 Q2 | 31.01 Million SAR | 21.59% |
| 2021 FY | 43.92 Million SAR | -71.33% |
| 2021 Q3 | 18.24 Million SAR | -41.16% |
| 2021 Q1 | 25.5 Million SAR | 435.88% |
| 2020 Q1 | 52.76 Million SAR | 118.98% |
| 2020 Q3 | 77.49 Million SAR | 82.38% |
| 2020 FY | 153.17 Million SAR | 258.03% |
| 2020 Q4 | 4.75 Million SAR | -93.86% |
| 2020 Q2 | 42.48 Million SAR | -19.47% |
| 2019 Q2 | -74.39 Million SAR | -2452.15% |
| 2019 FY | -96.92 Million SAR | -115.62% |
| 2019 Q3 | 51.38 Million SAR | 169.07% |
| 2019 Q4 | -277.93 Million SAR | -640.91% |
| 2019 Q1 | 3.16 Million SAR | -97.78% |
| 2018 Q3 | 3.57 Million SAR | -93.06% |
| 2018 Q1 | 69.52 Million SAR | 125.39% |
| 2018 FY | 620.4 Million SAR | 220.68% |
| 2018 Q4 | 142.43 Million SAR | 3889.03% |
| 2018 Q2 | 51.45 Million SAR | -26.0% |
| 2017 Q2 | 59.45 Million SAR | 15.49% |
| 2017 FY | 193.46 Million SAR | 20.69% |
| 2017 Q3 | 128.76 Million SAR | 116.59% |
| 2017 Q1 | 51.47 Million SAR | 774.55% |
| 2017 Q4 | -273.82 Million SAR | -312.65% |
| 2016 Q3 | 21.94 Million SAR | -60.04% |
| 2016 Q1 | 91.05 Million SAR | -7.07% |
| 2016 FY | 160.3 Million SAR | -38.82% |
| 2016 Q2 | 54.93 Million SAR | -39.67% |
| 2016 Q4 | -7.63 Million SAR | -134.77% |
| 2015 Q2 | 48.01 Million SAR | -47.43% |
| 2015 Q1 | 91.34 Million SAR | 1.8% |
| 2015 Q3 | 24.69 Million SAR | -48.57% |
| 2015 FY | 262.03 Million SAR | 8.3% |
| 2015 Q4 | 97.97 Million SAR | 296.76% |
| 2014 Q4 | 89.72 Million SAR | 186.97% |
| 2014 Q3 | 31.26 Million SAR | -26.62% |
| 2014 Q2 | 42.6 Million SAR | -45.61% |
| 2014 Q1 | 78.34 Million SAR | 27.37% |
| 2014 FY | 241.94 Million SAR | 16.92% |
| 2013 Q1 | 70.64 Million SAR | 12.38% |
| 2013 Q3 | 33.37 Million SAR | -17.87% |
| 2013 Q4 | 61.5 Million SAR | 84.29% |
| 2013 FY | 206.92 Million SAR | 3.28% |
| 2013 Q2 | 40.63 Million SAR | -42.48% |
| 2012 Q4 | 62.86 Million SAR | 58.71% |
| 2012 FY | 200.35 Million SAR | -6.79% |
| 2012 Q3 | 39.6 Million SAR | 0.0% |
| 2011 FY | 214.94 Million SAR | 12.56% |
| 2010 FY | 190.96 Million SAR | 12.11% |
| 2009 FY | 170.33 Million SAR | 258.37% |
| 2008 FY | -107.55 Million SAR | -10.74% |
| 2007 FY | -97.12 Million SAR | -194.03% |
| 2006 FY | 103.29 Million SAR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 313.37 Million SAR | 71.473% |